Our Team

Dr Fenu completed his PhD at the University of Glasgow on ‘Investigation of piezoelectric materials for ultrasonic surgery’ which focused on doped piezocrystals and lead-free piezoceramics for high-power, low-frequency ultrasonic applications. During the final year of his PhD, Dr Fenu joined the programme grant ‘Ultrasurge, Surgery enabled by Ultrasonics’ where he worked on miniaturised ultrasonic surgical tools for integration with robotics. In December 2021 Dr Fenu founded Nami Surgical Ltd. and he leads Nami’s activities as CEO. Dr Fenu is the key named inventor in the patent at the core of Nami Surgical technology.

From 2013 to 2018 she completed a PhD at the University of Glasgow researching the use of ultrasonic needles for bone penetration. During this period she was rewarded with the receipt of the R.W.B Stephens prize by Elsevier at the International Conference of Ultrasonics (ICU) and Dr Alan Stirling Brown Prize for her PhD thesis. After 3 years as a lead post-doctorate researcher within the Centre for Medical and Industrial Ultrasonics, Dr Cleary was a key member of the cohort who founded Nami Surgical Ltd. She leads Nami’s technical and regulatory activities as CTO.

While pursuing his studies, Alexandr demonstrated his entrepreneurial spirit by successfully building a manufacturing start-up from the ground up.

Upon joining Nami, Alexandr quickly made an impact by implementing innovative technology and rapidly accelerating the company’s product development process. With a unique blend of multidisciplinary expertise, including AI computing technologies, product design, and manufacturing, Alexandr consistently delivers exceptional solutions that push the boundaries of what is possible.

Thanks to his unwavering commitment to excellence and his innovative approach to problem-solving, Alexandr has become a driving force in our team. He serves as an inspiration to others, demonstrating what is possible when passion and expertise are combined.

He founded and led the Nanoelectronics Research Centre at Glasgow University for 12 years and was Head of Department of Electronics & Electrical Engineering there from 1994 to 1999. As co-founder and Technical Director of Intellemetrics Ltd, specialising in equipment for the control of thin-film deposition, Steve was responsible for all hardware and embedded software design of the company’s first products, sold throughout Europe, the US and Japan. His commitment to the enterprise agenda has since led to the foundation of Kelvin Nanotechnology Ltd and Compound Semiconductor Technology Ltd, providing services in nanotechnology and optoelectronic device fabrication respectively. He is currently a Director of CST’s successor company, CST Global Ltd.
From 1999 Steve was Director of the Institute for System Level Integration, an industry-facing organisation supported by five Universities which is supporting the growth of the system-on-chip design industry in the UK.
Steve has also been a Director of Electronics Scotland and a member of the Sector Skills Council Advisory Board for Electronics. He was awarded the OBE in the Jubilee Honours List 2002 for services to electronics and nanotechnology.
In January 2005 Steve moved back to Glasgow University to take up the position of Vice Principal for Research & Enterprise. He was responsible for the University’s research strategy, policies and operations, including knowledge transfer and commercialisation.
From 2014 – 2021 Steve was Director of QuantIC the UK quantum technology hub for quantum-enhanced imaging. QuantIC is currently in its second phase, and it’s mission is to demonstrate the opportunities that photon counting and timing, quantum entanglement together with machine learning can bring to address imaging challenges in industry and science.
He retired from the University at the end of 2021 but continues to hold the position of Honorary Senior Research Fellow in the School of Engineering.
He is also director of multiple spinout companies from Glasgow University and chairs the. Board of Vector Photonics Ltd. He is a member of the IET’s Quantum Engineering network steering committee and until 2021 was a founding member of the Royal Academy of Engineering’s Enterprise Committee.

Skilled in Marketing Management, Market Planning, Sales, Medical Devices, and Business Development. Strong sales professional with a Bachelor’s degree focused in Law & Accountancy from Staffordshire University.  Nikki is currently the Chief Commercial Officer for Summit and previously held a number of senior director sales and marketing roles in the surgical industry space with Orthosonics International, SRA Developments, Bowa Medical UK.

Specialities include preparing investor ready funding propositions and in identifying and negotiating the appropriate mix of equity, debt and grant funding. John also brings strong experience of the M&A market, inclusive of deal sourcing, project management and specialise in providing tailored financial due diligence services for these transactions. Since joining DC Consulting, John has advised on transactions with a combined value in excess of £75m across a myriad of sectors.

Prior to 2004, John spent a number of years as a Senior Audit Manager with Mazars, which assisted in developing my robust experience in the identification and implementation of financial systems and controls.

Finally, John also holds the position of non-executive Finance Director with a number of companies and assist them with their growth plans in a controlled manner, recognising the dynamic market that we operate in.

Helen has more than 35 years’ experience in global Regulatory Affairs, including senior positions in what are now Astra Zeneca, Sanofi, and GSK. She leads a team of very experienced regulatory professionals supporting pharmaceutical and medical device developments and applications in Europe, North America, SE Asia and Australasia.  Helen regularly lectures in EU/US regulatory requirements and is a Module leader for the TOPRA MSc on Medical Technology, on Design and Development of Medical Devices.  Helen is an accredited member of TOPRA (EU) and RAPS (USA), a Chartered Biologist (MRSB), a Member of the European Medical Writers Association and of the Institute of Directors.  She and her team regularly support University start-ups and spin-offs with their regulatory strategies / requirements and Helen is delighted to be a member of the Scientific Advisory Board.